Results 161 to 170 of about 259,832 (291)

Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

Arthritis &Rheumatology, Accepted Article.
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

National access to renal transplantation and post-transplant survival among patients with diabetes: deceased and living donor outcomes. [PDF]

BMJ Open Diabetes Res Care
Crest P, Stacey H, Barua S, Macdonald A, Sood P, Roberts JP.   +5 more
europepmc   +1 more source

Orthotopic liver transplantation in familial amyloidotic polyneuropathy is associated with long-term progression of renal disease

, 2012
Ana Carina Ferreira, Fernando Nolasco, Sandra Sampaio, Alexandre Baptista, Pedro Pessegueiro, Estela Monteiro, Eduardo Barroso   +6 more
openalex   +1 more source

Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers

British Journal of Clinical Pharmacology, EarlyView.
Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard, Diane Merino, Marc Labriffe, Fanny Rocher, Delphine Viard, Laurence Zemori, Thibaud Lavrut, Erik M. Donker, Joost D. Piët, Jean‐Paul Fournier, Milou‐Daniel Drici, Alexandre Destere   +11 more
wiley   +1 more source

Malignancies After Renal Transplantation: Frequency, Etiology, and Prognosis-A Single Center Experience. [PDF]

J Clin Med
Atalah F, Acarbay A, Karakök A, Beşiroğlu M, Kuş F, Arıcı H, Dirim AB, Suleymanova V, Türkmen A, Yazıcı H.   +9 more
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Improving renal transplant outcomes through the tubeless anesthesia technique in renal transplantation: a retrospective study. [PDF]

BMC Anesthesiol
Chen C, Ou J, Wu G, Liu H, Yang H, Fu S, Ran Z, Xie J, Xu X, He J, Yang C, Liu X.   +11 more
europepmc   +1 more source

One year follow-up of the cardio-metabolic profile evolution in renal transplant patients treated with alemtuzumab, cyclosporine, and steroids in a reference hospital in Colombia

, 2015
JF Nieto-Ríos, Narly Viviana Gómez, Lina María Serna-­Higuita, Catalina Ocampo-­Kohn, Arbey Aristizábal­-Alzate, Harry Abadía-Guzmán, Carlos Enrique Yepes Delgado, Gustavo Adolfo Zuluaga-­Valencia, G Zuluaga-Valencia   +8 more
openalex   +2 more sources

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Impact of polycystic kidney disease on outcomes after renal transplantation: systematic review and meta-analysis. [PDF]

Ren Fail
Liu C, Yan F, Zhong M, Niu Y.
europepmc   +1 more source